SE445466B - Sett att foroka rotavirus in vitro - Google Patents

Sett att foroka rotavirus in vitro

Info

Publication number
SE445466B
SE445466B SE7812283A SE7812283A SE445466B SE 445466 B SE445466 B SE 445466B SE 7812283 A SE7812283 A SE 7812283A SE 7812283 A SE7812283 A SE 7812283A SE 445466 B SE445466 B SE 445466B
Authority
SE
Sweden
Prior art keywords
cells
virus
rotavirus
medium
serum
Prior art date
Application number
SE7812283A
Other languages
English (en)
Swedish (sv)
Other versions
SE7812283L (sv
Inventor
J D Almeida
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE7812283L publication Critical patent/SE7812283L/xx
Publication of SE445466B publication Critical patent/SE445466B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12361—Methods of inactivation or attenuation
    • C12N2720/12364—Methods of inactivation or attenuation by serial passage

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE7812283A 1977-12-01 1978-11-29 Sett att foroka rotavirus in vitro SE445466B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5009477 1977-12-01
GB5390677 1977-12-24

Publications (2)

Publication Number Publication Date
SE7812283L SE7812283L (sv) 1979-06-02
SE445466B true SE445466B (sv) 1986-06-23

Family

ID=26266615

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7812283A SE445466B (sv) 1977-12-01 1978-11-29 Sett att foroka rotavirus in vitro

Country Status (10)

Country Link
US (1) US4205131A (enExample)
JP (1) JPS5495789A (enExample)
CH (1) CH646194A5 (enExample)
DE (1) DE2851928A1 (enExample)
DK (1) DK152516C (enExample)
FI (1) FI63060C (enExample)
FR (1) FR2410675A1 (enExample)
GB (1) GB2009786B (enExample)
NL (1) NL191183C (enExample)
SE (1) SE445466B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE33164E (en) * 1979-05-15 1990-02-13 Mobay Corporation Influenza vaccine production in liquid cell culture
US4500513A (en) * 1979-05-15 1985-02-19 Miles Laboratories, Inc. Influenza vaccine production in liquid cell culture
US4624850A (en) * 1984-02-09 1986-11-25 Royal Children's Hospital Research Foundation Live attenuated human rotavirus vaccine
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US5147639A (en) * 1990-06-19 1992-09-15 Ambico, Inc. Type-c rotavirus cultures and uses therefor
US5610049A (en) * 1991-05-01 1997-03-11 The Wistar Institute Of Anatomy And Biology Human rotavirus HCR3A and method of growing said rotavirus
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
CA2205015C (en) * 1994-11-10 2003-04-08 Otfried Kistner Method for producing biologicals in protein-free culture
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5756341A (en) * 1994-11-10 1998-05-26 Immuno Ag Method for controlling the infectivity of viruses
WO1998017785A1 (en) * 1996-10-18 1998-04-30 The Research Foundation For Microbial Diseases Of Osaka University Rotavirus antigens, vaccines and diagnostic drugs for infection with rotavirus, and processes for producing the same
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
US6656719B1 (en) * 1997-10-27 2003-12-02 Merck & Co., Inc. Serum-free, low-protein media for rotavirus vaccine production
FR2801900B1 (fr) * 1999-12-03 2004-02-27 Pasteur Merieux Serums Vacc Methode de production de cellules animales adherentes
US6830917B2 (en) * 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
WO2007093036A1 (en) * 2006-02-13 2007-08-23 Oncolytics Biotech Inc. Use of local immune suppression to enhance oncolytic viral therapy
CN101489587B (zh) * 2006-05-12 2015-05-27 伯哈拉特生物技术国际有限公司 一种可用作疫苗的组合物
CN117070475B (zh) * 2023-10-13 2023-12-29 金宇保灵生物药品有限公司 牛轮状病毒无血清悬浮培养方法及其产品和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1539221A (en) * 1976-09-30 1979-01-31 Wellcome Found Viral preparations

Also Published As

Publication number Publication date
JPS6150599B2 (enExample) 1986-11-05
DK542878A (da) 1979-06-02
NL191183B (nl) 1994-10-03
FR2410675B1 (enExample) 1983-12-16
DK152516C (da) 1988-08-01
DK152516B (da) 1988-03-07
FR2410675A1 (fr) 1979-06-29
NL191183C (nl) 1995-03-01
US4205131A (en) 1980-05-27
FI63060C (fi) 1983-04-11
GB2009786A (en) 1979-06-20
FI63060B (fi) 1982-12-31
FI783663A7 (fi) 1979-06-02
DE2851928C2 (enExample) 1987-06-04
GB2009786B (en) 1982-08-11
SE7812283L (sv) 1979-06-02
NL7811763A (nl) 1979-06-06
DE2851928A1 (de) 1979-06-21
JPS5495789A (en) 1979-07-28
CH646194A5 (de) 1984-11-15

Similar Documents

Publication Publication Date Title
SE445466B (sv) Sett att foroka rotavirus in vitro
JP5264843B2 (ja) 細胞培養におけるインフルエンザウイルスの複製の方法、および本方法によって入手可能なインフルエンザウイルス
Fraser et al. Increased tendency to spontaneous in-vitro lymphocyte transformation in clinically active multiple sclerosis
US5071758A (en) Production of cell strains capable of propagating respiratory syncytial virus, compositions containing such virus and their use in diagnosis of respiratory syncytial virus infection
US3959466A (en) Highly attenuated cytomegalovirus vaccine and production thereof
Dorson et al. Infectious pancreatic necrosis virus of salmonids: biological and antigenic features of a pathogenic strain and of a non‐pathogenic variant selected in RTG‐2 cells
CA1162147A (en) Feline vaccines
Hasegawa et al. Isolation of human rotaviruses in primary cultures of monkey kidney cells
Boyer Chorioallantoic membrane lesions produced by inoculation of adult fowl leucocytes
Mogensen et al. Role of activated macrophages in resistance of congenitally athymic nude mice to hepatitis induced by herpes simplex virus type 2
Manaker et al. Long-term propagation of a murine leukemia virus in an established cell line
Blaškovič et al. Experimental infection of weanling pigs with A/Swine influenza virus: 2. The shedding of virus by infected animals
EP0125245A1 (en) PROPAGATION OF BLEEDING ENTERAL VIRUS IN TURKEY CELLS.
Karpas et al. Sinus histiocytosis with massive lymphadenopathy: virological, immunological and morphological studies
Kilham Transformation of fibroma into myxoma virus in tissue culture
US3616203A (en) Virus culture and method
US3493651A (en) Production of viral vaccines
Li et al. Serum neutralization tests in mice and in tissue culture against three types of poliomyelitis virus
US3432595A (en) Melanoma cell line of canine origin,its propagation and use,and vaccines derived therefrom
Igarashi A mutant of Chikungunya virus isolated from a line of Singh's Aedes albopictus cells by plaque formation on virus-sensitive cloned cells obtained from another Singh's A. albopictus cell line
Buckley et al. Production of hemagglutinin by dengue virus in HeLa cells
US5514376A (en) Cell culture of hepatitis A virus
SU1518370A1 (ru) Штамм культивируемых клеток кожи и мышц эмбриона человека дл изготовлени диагностических препаратов
CN118792263A (zh) 以mrc-5细胞制备高滴度狂犬病病毒的方法及应用
Smith et al. A Report on the Attempted Isolation of the Virus of Trachoma

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7812283-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7812283-5

Format of ref document f/p: F